Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Abdulmalik Alkatheri"'
Autor:
Amani Kurdi, Waleed Alhussaini, Abdulrahman Alawaji, Abdullah Alhudathi, Rakan Alharbi, Faisal Binsaleh, Yazeed Alghamidi, Abdulkareem Al Bekairy, Abdulmalik Alkatheri, Imadul Islam, Ibrahim Farh, Ezzeldeen Ghanem, Mahmoud Mansour
Publikováno v:
Heliyon, Vol 10, Iss 12, Pp e32551- (2024)
The present study compared the performance of Ultra-high performance liquid chromatography (UHPLC) and UV–Vis spectrophotometry for the quantification of metformin hydrochloride in five commercially available metformin hydrochloride products with d
Externí odkaz:
https://doaj.org/article/672a653fa7f04ec9801df8201397375a
Autor:
Khalid A. Al Sulaiman, Ohoud Aljuhani, Khalid Eljaaly, Aisha A. Alharbi, Adel M. Al Shabasy, Alawi S. Alsaeedi, Mashael Al Mutairi, Hisham A. Badreldin, Shmeylan A. Al Harbi, Hussain A. Al Haji, Omar I. Al Zumai, Ramesh K. Vishwakarma, Abdulmalik Alkatheri
Publikováno v:
International Journal of Infectious Diseases, Vol 105, Iss , Pp 180-187 (2021)
Background: Coronavirus disease-19 (COVID-19) manifested by a broad spectrum of symptoms, ranging from asymptomatic manifestations to severe illness and death. The purpose of the study was to extensively describe the clinical features and outcomes in
Externí odkaz:
https://doaj.org/article/94d694f86ae24977bb61ea2343a59362
Autor:
Isra Al-Rashoud, Maha Al-Ammari, Hisham Al-Jadhey, Abdulmalik Alkatheri, Gregory Poff, Tariq Aldebasi, Salah AbuRuz, Abdulkareem Al-Bekairy
Publikováno v:
Saudi Pharmaceutical Journal, Vol 25, Iss 7, Pp 1082-1085 (2017)
Externí odkaz:
https://doaj.org/article/a1cbaff1d6be41c2bd3ecdcf0f96297d
Autor:
Hind Almodaimegh, Lama Alfehaid, Nada Alsuhebany, Rami Bustami, Shmylan Alharbi, Abdulmalik Alkatheri, Abdulkareem Albekairy
Publikováno v:
Thrombosis Journal, Vol 15, Iss 1, Pp 1-8 (2017)
Abstract Background Patient awareness of venous thromboembolism (VTE) and thromboprophylaxis is essential for their safety. In this study, we evaluated patients’ awareness of VTE and their perceptions of thromboprophylaxis. Methods We administered
Externí odkaz:
https://doaj.org/article/9b0e1a3ae2384bf8b524772f269992ec
Autor:
Abdulmalik Alkatheri, Abdulkareem Al Bekairy, Salah Aburuz, Amjad Qandil, Nabil Khalidi, Khalid Abdullah, Sayyari Al Sayyari, Rami Bustami, Shmeylan Al Harbi, Sultan Al Raddadi, Khalifah Al Thiab, Khalid Bin Saleh, Abdulrahman Al Shaya
Publikováno v:
Annals of Saudi Medicine, Vol 35, Iss 5, Pp 368-376 (2015)
BACKGROUND AND OBJECTIVES: Despite the worldwide recognition of the importance of quality of life (QOL) assessment, research data on QOL for renal and liver transplant recipients are limited. The main objective of this study was to explore and compar
Externí odkaz:
https://doaj.org/article/b0fc99abc85648f997d2e0a0689acb2e
Autor:
Abdulmalik Alkatheri
Publikováno v:
Pharmaceuticals, Vol 6, Iss 1, Pp 25-31 (2013)
Recombinant tissue plasminogen activator (rt-PA) is used to restore patency and avoid inadvertent removal of peripheral and central venous catheters. rt-PA was reconstituted (1 mg/mL) then cryopreserved at −30 °C for 1, 2, 3, 6, 8, and 12 months a
Externí odkaz:
https://doaj.org/article/d5d355063a5640108a0dad9bcade1f7f
Autor:
Abdulkareem Albekairy, Abdulmalik Alkatheri, Shiro Fujita, Alan Hemming, Richard Howard, Alan Reed, Janet Karlix
Publikováno v:
The Saudi Journal of Gastroenterology, Vol 19, Iss 2, Pp 89-95 (2013)
Background and Aims: Tacrolimus is a macrolide immunosuppressant used for prevention of allograft rejection in organ transplantation and metabolized in the liver and intestine by cytochrome P450 3A4 (CYP3A4) enzyme. A single nucleotide polymorphism (
Externí odkaz:
https://doaj.org/article/7d1f07566b124485b95c161d2d8d0f55
Autor:
Abdulkareem M Albekairy, Mohammad S Shawaqfeh, Shroug H Alharbi, Faisal Almuqbil, Mesfer A Alghamdi, Nataleen A Albekairy, Suhaib M Muflih, Abdulmalik Alkatheri
Publikováno v:
Transplant Research and Risk Management.
Abdulkareem M Albekairy,1â 3 Mohammad S Shawaqfeh,1,2 Shroug H Alharbi,3,4 Faisal Almuqbil,1,2 Mesfer A Alghamdi,3,5 Nataleen A Albekairy,6 Suhaib M Muflih,7 Abdulmalik Alkatheri1â 3 1Department of Pharmacy Practice, College of Pharmacy, Ki
Autor:
Abdulmalik Alkatheri, Abdelkareem Albekairy, Yousef Al-Rajhi, Shamylan AlHarbi, Khalifah Alkhamees, Fayez F. Hejaili, Rami Bustami, Wesam Abdel-Razaq, Amjad M. Qandil, Mahmoud Mansour
Publikováno v:
International Journal of Medical Research and Health Sciences, Vol 5, Iss 12, Pp 335-342 (2016)
Anemia is the most common side effect in patients with chronic kidney disease (CKD) mainly due to lower levels of erythropoietin (EPO) hormone. The aim of the present study is to compare the efficacy of equivalent doses of erythropoiesis stimulating